Related Experiment Video

Updated: Aug 15, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

The role of thrombolytic therapy for acute myocardial infarction

J S Reiner1, A G Wasserman

  • 1Department of Medicine, George Washington University, Washington, DC 20037.

Coronary Artery Disease
|May 1, 1994
PubMed

Insights

Thrombolytic therapy restores coronary artery blood flow, improving heart function and survival. However, achieving optimal flow remains a challenge, necessitating new strategies to enhance outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Thrombolytic therapy is a key treatment for restoring blood flow in occluded arteries.
  • While effective, current thrombolytic regimens achieve optimal flow in only 50% of patients.
  • Achieving normal flow (TIMI grade 3) is crucial for reducing mortality and preserving ventricular function.

Purpose of the Study:

  • To review the efficacy of thrombolytic therapy in restoring infarct-related artery (IRA) patency.
  • To discuss strategies for improving early IRA perfusion and patient outcomes.
  • To highlight the role of adjunctive therapies like heparin in reducing reocclusion.

Main Methods:

  • Review of existing literature on thrombolytic therapy and adjunctive treatments.
  • Analysis of factors influencing IRA patency and patient mortality.
  • Discussion of novel approaches to enhance thrombolytic efficacy.

Main Results:

  • Thrombolysis restores IRA flow, salvages ventricular function, and reduces mortality.
  • Concomitant heparin use can decrease the risk of reocclusion after t-PA.
  • Optimal benefit is linked to early normal IRA perfusion (TIMI grade 3).

Conclusions:

  • Despite benefits, current thrombolytic strategies have limitations in achieving early optimal flow.
  • New therapeutic strategies, including different dosing, combinations, and novel agents, are needed.
  • Advancements hold promise for increasing early patency and further improving survival and cardiac function.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...